We developed an enzymatic method for determination of 5-fluorocytosine in serum, using creatine iminohydrolase (EC 3.5.4.21), the Cobas-Bio analyzer, and an extant ammonia method. Analytical recovery(y)of drug added to serum (.,) was good, with y = 0.97x -0.7, S = 3.6, r = 0.997 (n = 65) over the range 6.25 to 150 mg/L. Comparison with an HPLC method (x) showed good agreement: y = 0.98x + 1.34, S, = 3.7 (n = 37), as analyzed with the Deming debiased regression. Precision was good, CVs being <3% for within-run and <6% for between-run controls. Ammonia, amphotencin B, glucose, urea, and hemolysis do not interfere, but bilirubin shows analyte-dependent interference and lipemia interferes when triglycerides exceed 5 g/L. This assay is accurate, inexpensive, and easy to perform. It can be easily adapted for routine or emergency use. used in the Kodak Ektachem, which was easier to perform then those mentioned above.
lipemia interferes when triglycerides exceed 5 g/L. This assay is accurate, inexpensive, and easy to perform. It can be easily adapted for routine or emergency use. used in the Kodak Ektachem, which was easier to perform then those mentioned above.
In the Ektachem method, creatinine iminohydrolase cleaved ammonia from both creatinine and 5-fluorocytosine.
The ammonia then diffused through a semipermeable layer and reacted with the indicator, bromphenol blue. Measurement of 5-fluorocytosine with the Ektachem involved ammonia and creatinine slides and required measurement of creatinine by the Jaff#{233} reaction (9, 10). This method required the use of an Ektachem, and problems with linearity and interferences have not been resolved, mainly because the Ektachem method was not designed to measure 5-fluorocytosine. Furthermore, Kodak may plan to alter the sensitivity of their creatimne slides to 5-fluorocytosine, making the Ektachem method defunct. Seeking a moreavailable method, we developed an automated procedure to measure 5-fluorocytosine, using creatiine iminohydrolase, a centrifugal analyzer,and an extant method for ammonia. 
MaterIals and Methods

Apparatus
We used a Cobas-Bio centrifugal analyzer (Roche Analyti- 
As possible interferants
we tested 5-fluorouracil, urea (Sigma), and Fungizone for injection (50mg of amphotericin B plus 41 mg of sodium deoxycholate per vial; Squibb Inc., Princeton, NJ 08540).
Controls
We used aqueous-based controls (stable for three months) for between-run and serum-based controls for within-run evaluation of precision.
We made the former by adding 5-fluorocytosine to the Tris buffer. We made the latter by adding the drug to a serum pool. Both sets of controlswere stored at -20 #{176}C.
Enzymatic assays
The assay is based on the following reactions: 
where a = 1/B. We use equation 2 to calculate the concentration of 5-fluorocytosine from the absorbance. In our case, a = 0.573, b = 2.062, and c = 10.
To run the assay, we first mix 10 L of sample with 260 L of the ammonia reagent, incubate at 37 #{176}C for 5 mm, and measure the absorbance at 340 nm for the blank, Ablapjc, to take into account the contribution of endogenous ammonia. Then, we add 20 pL of creatinine iminohydrolase ("start reagent"), incubate for 20 mm at 37 #{176}C, and measure the absorbance at 340 nm. The decrease in absorbance, #{163}4 = Ablan -A20 mm, is directly related to the concentration of ammonia released by action of the creatinine iminohydrolase. Table 1 lists the instrument settings.
In addition to the customary uses of the controls, we applied other tests. For each run, we divided the change in absorbance by the concentration of the aqueous controls to obtain the slope D. Slope D, from the controls, must agree with the slope D from the standardization with an allowed CV of 1.5%. We also divided the change in absorbance by the -biased regression (13, 14) . We tested the effect of creatimne and total bilirubin with an analyte-dependent The enzymatic method compared well with HPLC ( Figure  1B) . The Deming de-biased regression between the HPLC (x) and our method (y) wasy = 0.98x+ 1.34, S = 3.7, with n = 37.
Precision was satisfactory, with CVs <2.2% for withinrun and <5.4% for between-run controls (Table 2) .
Ammonia, amphotericin B, 5-fluorouracil, glucose, urea, and grossly hemolyzed specimens did not interfere with the method. Lipemic sera did interfere, showing a positive bias of 4 mg of apparent 5-fluorocytosine per gram of triglyceride. The interference of total bilirubin was analyte-dependent, being equal to 0.016 x [5-fluorocytosinel [total bilirubin], for concentrations of total bilirubin <70 mg/L and 5-fluorocytosine 80 mg/L. The interference beyond these concentrations is more complex, and there may be inaccuracies with icteric samples.
Discussion
5-Fluorocytosine can be a useful adjunct to amphotericin B in treating certain patients with cryptococcalmeninigitis or disseminated candidiasis. Its use has been limited, however, because it is difficult to monitor in a timely fashion. The enzymatic method presented here can solve this problem and make the assay more readily and widely available.
Our assay is accurate, its range beinglinear up to 150 mg 
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sera, but only 20 mm of technologist's time. Serum 5-fluorocytosine is stable for a week at 0 #{176}C, longer at -20 #{176}C, so samples can be accumulated and run simultaneously. This enzymatic method is more economical and easier to perform than the others.
The method can be adapted easily for routine or urgent use and should be an asset in management of patients who are In the comparison of the enzymatic method with HPLC, the slope was 0.98 when analyzed with the Deming debiased regression. This slope shows that the two methods agree well; thus the enzymatic method could be used in place of the HPLC method.
Our method had good precision, the CV being 5.3% or less (Table 2) for both within-run and between-run controls.
Even at the sub-therapeutic concentration of 6.5 mg of 5-fluorocytosine per liter, the within-run CV was only 8%. This degree of precision is acceptable because the therapeutic range is between 50 and 100 mg of 5-fluorocytosine per liter.
